https://events.reutersevents.com/pharma/pharma-europe
Top line data on the ATTRACT study
C21 shows promise against COVID-19 where other drugs have failed
Report on the ATTRACT study
Idiopathic Pulmonary Fibrosis: 5 Things to Know
Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients